gemcitabine has been researched along with Debility in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cordoba, R; Eyre, TA; Luminari, S | 1 |
| Gilabert, M; Raoul, JL; Rousseau, F | 1 |
| Álvarez, R; Carrato, A; Díaz, R; García, A; Hidalgo, M; Laquente, B; Macarulla, T; Muñoz, A; Sastre, J | 1 |
3 review(s) available for gemcitabine and Debility
| Article | Year |
|---|---|
The use of frailty assessments in treating older adults with aggressive lymphomas.
Topics: Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Disease Management; Doxorubicin; Frailty; Gemcitabine; Geriatric Assessment; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Rituximab; Vincristine | 2021 |
How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?
Topics: Adenocarcinoma; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Frailty; Gemcitabine; Geriatric Assessment; Humans; Neoplasm Staging; Palliative Care; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy | 2017 |
Management and supportive treatment of frail patients with metastatic pancreatic cancer.
Topics: Aged; Aged, 80 and over; Albumins; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Deoxycytidine; Fluorouracil; Frail Elderly; Frailty; Gemcitabine; Humans; Leucovorin; Organoplatinum Compounds; Paclitaxel; Pancreatic Neoplasms; Randomized Controlled Trials as Topic | 2019 |